Antiviral Research

New developments in the epidemiology, natural history and management of genital herpes
pp. 1-14(14)
Authors: Stanberry L.; Cunningham A.; Mertz G.; Mindel A.; Peters B.; Reitano M.; Sacks S.; Wald A.; Wassilew S.; Woolley P.

Resistance mutations selected in vivo under therapy with anti-HIV drug HBY 097 differ from resistance pattern selected in vitro
pp. 15-24(10)
Authors: Rubsamen-Waigmann H.; Huguenel E.; Shah A.; Paessens A.; Ruoff H.-J.; von Briesen H.; Immelmann A.; Dietrich U.; Wainberg M.A.

The effects of antirhino- and enteroviral vinylacetylene benzimidazoles on cytochrome P450 function and hepatic porphyrin levels in mice
pp. 25-33(9)
Authors: Tebbe M.J.; Jensen C.B.; A. Spitzer W.; Franklin R.B.; George M.h.; Phillips D.L.

Guanosine nucleotide analogs as inhibitors of alphavirus mRNA capping enzyme
pp. 35-46(12)
Authors: Lampio A.; Ahola T.; Darzynkiewicz E.; Stepinski J.; Jankowska-Anyszka M.; Kaariainen L.

Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA
pp. 47-57(11)
Authors: Lazarev V.N.; Shmarov M.M.; Zakhartchouk A.N.; Yurov G.K.; Misurina O.U.; Akopian T.A.; Grinenko N.F.; Grodnitskaya N.G.; Kaverin N.V.; Naroditsky B.S.

In vitro effect of amantadine and interferon -2a on hepatitis C virus markers in cultured peripheral blood mononuclear cells from hepatitis C virus-infected patients
pp. 59-70(12)
Authors: Martn J.; Navas S.; Fernandez M.; Rico M.; Pardo M.; Quiroga J.A.; Zahm F.; Carreno V.

Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: combined effect for both infections, an obtainable goal?
pp. 71-76(6)
Authors: Wolters L.M.M.; Niesters H.G.M.; de Man R.A.; Schalm S.W.